Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer

International Braz J Urol

Volumn 34, Issue 4, 2008, Pages 443-450

  DiBlasio, Christopher J ^a   Derweesh, Ithaar H ^a   Malcolm, John B ^a   Maddox, Michael M ^a   Aleman, Michael A ^a   Wake, Robert W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cryoablation; Erectile dysfunction; Prostatic neoplasms; Voiding dysfunction

Indexed keywords

EID: 56349106069     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382008000400006     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66.
2. Penson DF, Litwin MS: Quality of life after treatment for prostate cancer. Curr Urol Rep. 2003; 4: 185-95.
3. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M: Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002; 60: 3-11.
4. Chin JL, Ng CK, Touma NJ, Pus NJ, Hardie R, Abdelhady M, et al.: Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis. 2008; 11: 40-5.
5. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al.: Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003; 170: 1126-30.
6. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V: Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology. 2007; 70: 117-21.
7. Wake RW, Hollabaugh RS Jr, Bond KH: Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol. 1996; 155: 1663-6.
8. Donnelly BJ, Saliken JC, Ali-Ridha N, Rewcastle JC, White LJ: Histological findings in the prostate two years following cryosurgical ablation. Can J Urol. 2001; 8: 1237-9.
9. Anastasiadis AG, Sachdev R, Salomon L, Ghafar MA, Stisser BC, Shabsigh R, et al.: Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003; 129: 676-82.
10. Ellis DS: Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology. 2002; 60: 34-9.
11. Ellis DS, Manny TB Jr, Rewcastle JC: Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007; 69: 306-10.
12. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr: Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001; 57: 518-23.
13. Robinson JW, Donnelly BJ, Saliken JC, Weber BA, Ernst S, Rewcastle JC: Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology. 2002; 60: 12-8.
14. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC: Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006; 20: 688-92.
15. Lambert EH, Bolte K, Masson P, Katz AE: Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007; 69: 1117-20.
16. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al.: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992; 148: 1549-57; discussion 1564.
17. Horwitz EM, Vicini FA, Ziaja EL, Dmuchowski CF, Stromberg JS, Martinez AA: The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys. 1998; 41: 267-72.
18. Powell IJ, Dey J, Dudley A, Pontes JE, Cher ML, Sakr W, et al.: Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology. 2002; 59: 907-12.
19. Tewari A, Horninger W, Pelzer AE, Demers R, Crawford ED, Gamito EJ, et al.: Factors contributing to the racial differences in prostate cancer mortality. BJU Int. 2005; 96: 1247-52.
20. Mulhall JP, Morgentaler A: Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med. 2007; 4: 538-43.